Biotech & Bioprocessing

The landscape of synthetic biology has undergone a profound transformation with the emergence of Evo 2, a generative DNA model that shifts the focus from simple observation to active creation. While previous genomic tools were primarily designed to predict or analyze existing sequences, this new

The landscape of metabolic medicine is currently undergoing a profound transformation as therapeutic strategies shift from simple single-pathway interventions toward increasingly sophisticated multi-receptor modulation. At the very center of this evolution is UBT251, a long-acting synthetic peptide

The high-stakes world of oncology has long viewed triple-negative breast cancer as a fortress that resists the most sophisticated modern weapons, leaving patients and physicians with few options beyond traditional chemotherapy. This aggressive subtype, notorious for its rapid progression and lack

The clinical landscape for treating metastatic castration-resistant prostate cancer is undergoing a fundamental transformation as researchers pivot from conventional hormonal therapies toward high-precision immunotherapy. While androgen receptor pathway inhibitors have long served as the backbone

The persistent challenge of hospital-acquired infections remains a critical hurdle for healthcare systems across West Africa, often stemming from the inadequate containment of hazardous clinical materials. In a landscape where the safe disposal of infectious waste can determine the success of

The complex machinery of modern drug development often grinds to a halt not because a molecule fails to perform in a petri dish, but because the human element of clinical research proves too difficult to assemble. On February 20, the pharmaceutical giant Roche announced the official discontinuation